Related references
Note: Only part of the references are listed.Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms
Rong En Tay et al.
CANCER GENE THERAPY (2021)
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer
Mei-Yin C. Polley et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
Guoxuan Gao et al.
BMC CANCER (2020)
Spatially-resolved quantification of proteins in triple negative breast cancers reveals differences in the immune microenvironment associated with prognosis
Rachel L. Stewart et al.
SCIENTIFIC REPORTS (2020)
PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer
Fahad Shabbir Ahmed et al.
CLINICAL CANCER RESEARCH (2020)
PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer
Haiying Zhu et al.
DRUG DISCOVERY TODAY (2020)
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
Yu-Pei Chen et al.
CELL RESEARCH (2020)
Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma
Andrea Ladanyi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics
Mayar Allam et al.
NPJ PRECISION ONCOLOGY (2020)
Natural killer cells in cancer biology and therapy
Song-Yang Wu et al.
MOLECULAR CANCER (2020)
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy
Maria Vittoria Dieci et al.
EUROPEAN JOURNAL OF CANCER (2020)
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma
Anne Froehlich et al.
EBIOMEDICINE (2020)
Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives
Jin-Yu Sun et al.
BIOMARKER RESEARCH (2020)
Spatial immune profiling of the colorectal tumor microenvironment predicts good outcome in stage II patients
Ines P. Nearchou et al.
NPJ DIGITAL MEDICINE (2020)
Modeling Multiplexed Images with Spatial-LDA Reveals Novel Tissue Microenvironments
Zhenghao Chen et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2020)
DNA methylation markers predict recurrence-free interval in triple-negative breast cancer
Mary Jo Fackler et al.
NPJ BREAST CANCER (2020)
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
Tina Gruosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
A Multigene Assay Determines Risk of Recurrence in Patients with Triple-Negative Breast Cancer
Rachel L. Stewart et al.
CANCER RESEARCH (2019)
Applications of machine learning in drug discovery and development
Jessica Vamathevan et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Computational approaches for characterizing the tumor immune microenvironment
Candace C. Liu et al.
IMMUNOLOGY (2019)
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
Weilei Hu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation
Sandra Romero-Cordoba et al.
CANCERS (2019)
Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer
H. Vihervuori et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Immune effector monocyte-neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer
Catharina Hagerling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Exploring specific prognostic biomarkers in triple-negative breast cancer
Chang Bao et al.
CELL DEATH & DISEASE (2019)
Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents
Matteo Santoni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
Paula Michea et al.
NATURE IMMUNOLOGY (2018)
Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
Claudia Omarini et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging
Yury Goltsev et al.
CELL (2018)
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Leeat Keren et al.
CELL (2018)
Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy
Marinos Tsiatas et al.
CANCER MEDICINE (2018)
Triple negative breast cancer - prognostic role of immune-related factors: a systematic review
Elisabeth Specht Stovgaard et al.
ACTA ONCOLOGICA (2018)
Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling
In Ah Park et al.
PLOS ONE (2017)
Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity
Ruth Dannenfelser et al.
ONCOTARGET (2017)
Tumor-infiltrating CD45RO+ Memory T Lymphocytes Predict Favorable Clinical Outcome in Solid Tumors
Guoming Hu et al.
SCIENTIFIC REPORTS (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Biomarkers of response to PD-1/PD-L1 inhibition
Saman Maleki Vareki et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer
Aziza E. Abdelrahman et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2017)
An Immune Atlas of Clear Cell Renal Cell Carcinoma
Stephane Chevrier et al.
CELL (2017)
Tumor-infiltrating CD45RO+ memory cells are associated with a favorable prognosis breast cancer
Reina Yajima et al.
BREAST CANCER (2016)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
Deep Learning Automates the Quantitative Analysis of Individual Cells in Live-Cell Imaging Experiments
David A. Van Valen et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. Raza Ali et al.
PLOS MEDICINE (2016)
Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers
Yong Yue et al.
PLOS ONE (2016)
β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
Jinhua Xu et al.
PLOS ONE (2015)
Human breast cancer cells educate macrophages toward the M2 activation status
Sofia Sousa et al.
BREAST CANCER RESEARCH (2015)
Multiplexed ion beam imaging of human breast tumors
Michael Angelo et al.
NATURE MEDICINE (2014)
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
Charlotte Giesen et al.
NATURE METHODS (2014)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
John Stagg et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2013)
Understanding the biology of triple-negative breast cancer
C. Criscitiello et al.
ANNALS OF ONCOLOGY (2012)
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
Fiona M. Blows et al.
PLOS MEDICINE (2010)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Share Paper
